After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, UTHR falls under the Healthcare sector while operating within the Drug Manufacturers – Specialty & Generic industry segment. The current market capitalization of United Therapeutics Corp is $18.89B. A total of 1.94 million shares were traded on the day, compared to an average of 687.05K shares.
Insider Activity
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, UTHR has seen 29 BUY and 99 SELL insider trades, representing the acquisition of 167,085 and the disposition of 163,316 shares. Over the last 12 months, there were 130 BUYs and 490 SELLs from insiders. Insiders purchased 891,799 shares during that period but sold 907,531.
In the most recent transaction, ROTHBLATT MARTINE A bought 4,000 shares of UTHR for 411.08 per share on Sep 19 ’25. In a previous transaction on Sep 19 ’25, Olian Judy D. sold 1,800 shares at 415.43 per share. UTHR shares that Director owns now total 5,045.
Among the insiders who bought shares, JUDY OLIAN acquired of 1,800 shares on Sep 19 ’25 at a per-share price of $415.43. In another insider transaction, MAHON PAUL A sold 11,000 shares at $406.17 per share on Sep 18 ’25. Company shares held by the EVP & GENERAL COUNSEL now total 36,781.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, UTHR has a high of $436.95 and a low of $266.98.
As of this writing, UTHR has an earnings estimate of $6.94 per share for the current quarter. EPS was calculated based on a consensus of 11.0 estimates, with a high estimate of $7.67 per share and a lower estimate of $6.08. The company reported an EPS of $6.39 in the last quarter
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. UTHR’s latest balance sheet shows that the firm has $1.93B in Cash & Short Term Investments as of fiscal 2021. There were $800.00M in debt and $305.40M in liabilities at the time. Its Book Value Per Share was $158.65, while its Total Shareholder’s Equity was $3.96B.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock.
